Rafarma Pharmaceuticals Inc. has published an amendment to their management certification for the year ending December 31, 2024. The document, originally issued on May 13, 2025, has been restated to include a required list of officers. It is important to note that this amendment was automatically generated by OTC Markets Group based on Rafarma's provided information, and OTC Markets Group disclaims any responsibility for the content of this restatement. The restated document does not specifically indicate whether the financial results themselves have been audited, and it primarily focuses on administrative updates and compliance.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。